The use of locoregional therapies in cholangiocarcinoma
Listen to this summary
This literature review investigates the role of locoregional therapies in managing unresectable or advanced cholangiocarcinoma (CCA), particularly intrahepatic (iCCA) and perihilar CCA (pCCA). The authors aim to evaluate the clinical outcomes of various locoregional treatments compared to the standard systemic chemotherapy and immunotherapy, highlighting the need for individualized treatment strategies until more robust evidence from randomized controlled trials is available. The findings suggest a trend towards integrating locoregional therapies with standard care to improve patient outcomes.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of hepatology
View all →Sep 22, 2026 · Journal of hepatology
Restoration of aged liver regeneration by youthful systemic factors via LTβ-driven hepatocyte reprogramming
Sep 15, 2026 · Journal of hepatology
Systemic therapy for HCC: Doublets, triplets and beyond
Sep 15, 2026 · Journal of hepatology
Advances in the imaging of liver cancer
Sep 15, 2026 · Journal of hepatology
Integrating systemic therapy in the earlier stages of liver cancer
Sep 15, 2026 · Journal of hepatology
Liver transplantation for primary liver cancers in the era of transplant oncology
Sep 11, 2026 · Journal of hepatology
Mouse models of acute and chronic hepatitis E virus infection
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


